Aaron Shelub in Tarzana, California

Home California Tarzana

Aaron Shelub has Infectious Disease as his primary medical specialty. Their primary office is: 18370 Burbank Blvd in Tarzana, California.

They're a part of the: Comprehensive Infectious Disease Consultants A Medical Corporation medical group which has around 2 members. You can call their office at 818-506-3384 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2003 (around 21 years of experience). They are listed as doing telehealth appointments.

Aaron M Shelub Office Phone and Directions

Aaron Shelub
Comprehensive Infectious Disease Consultants A Medical Corporation
18370 Burbank Blvd
Tarzana, California 91356
818-506-3384

Patient Ratings
Please rate your experience with Aaron Shelub below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 818-506-3384

Enter a starting address:

Healthcare Info for Aaron Shelub

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2003
The Primary Medical Specialty for Aaron Shelub is listed as: Infectious Disease
Approximate Years of Experience: 21
PAC (PECOS ID)#: 0143382291
NPI #: 1124103619
NPI Created On: 10/25/2006
NPI Last Updated Listed as: 10/28/2016
Primary Taxonomy Code: 174400000X
License Number:
A92108
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Hebrew.

Services and Procedures include:

New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Critical care delivery critically ill or injured patient, first 30-74 minutes
Critical care delivery critically ill or injured patient
Initial nursing facility visit, typically 35 minutes per day
Initial nursing facility visit, typically 45 minutes per day
Initial nursing facility visit, typically 45 minutes per day
Subsequent nursing facility visit, typically 35 minutes per day
Prolonged inpatient or observation hospital service first hour
Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge
Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 813528485

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTIBIOTIC

Name of Drug #1: NUZYRA

Open Associated Drug #1: 71715-002-21

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796025465

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796025467

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796025469

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796025471

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 846746061

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTIBIOTICS

Name of Drug #1: Orbactiv

Open Associated Drug #1: 70842-140-03

Drug or Biological: Drug

Product Category #2: ANTIBIOTICS

Name Of Drug #2:: Vabomere

Associated Drug #2: 70842-120-06

Drug or Biological #3:: Drug

Product Category #3: ANTIBIOTICS

Name of Drug: Baxdela

Name Of Drug #3: 70842-102-03

Drug or Biological: Drug

Product Category #4: ANTIBIOTICS

Name of Drug #4: Minocin

Associated Drug #4: 70842-160-10

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 846746811

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTIBIOTICS

Name of Drug #1: Kimyrsa

Open Associated Drug #1: 70842-225-01

Drug or Biological: Drug

Product Category #2: ANTIBIOTICS

Name Of Drug #2:: Orbactiv

Associated Drug #2: 70842-140-03

Drug or Biological #3:: Drug

Product Category #3: ANTIBIOTICS

Name of Drug: Vabomere

Name Of Drug #3: 70842-120-06

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848508957

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: INFECTIOUS DISEASE

Name of Drug #1: PIFELTRO

Open Associated Drug #1: 0006-3069-01

Drug or Biological: Drug

Product Category #2: INFECTIOUS DISEASE

Name Of Drug #2:: ISENTRESS

Associated Drug #2: 0006-0477-61

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848735059

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: INFECTIOUS DISEASE

Name of Drug #1: DIFICID

Open Associated Drug #1: 52015-080-01

Drug or Biological: Drug

Product Category #2: INFECTIOUS DISEASE

Name Of Drug #2:: RECARBRIO

Associated Drug #2: 0006-3856-02

Drug or Biological #3:: Biological

Product Category #3: INFECTIOUS DISEASE

Name of Drug: ZINPLAVA

Name Of Drug #3: 0006-3025-00

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848735123

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: INFECTIOUS DISEASE

Name of Drug #1: PIFELTRO

Open Associated Drug #1: 0006-3069-01

Drug or Biological: Drug

Product Category #2: INFECTIOUS DISEASE

Name Of Drug #2:: ISENTRESS

Associated Drug #2: 0006-0477-61

Drug or Biological #3:: Drug

Product Category #3: INFECTIOUS DISEASE

Name of Drug: DIFICID

Name Of Drug #3: 52015-080-01

Drug or Biological: Drug

Product Category #4: INFECTIOUS DISEASE

Name of Drug #4: DELSTRIGO

Associated Drug #4: 0006-5007-01

Infectious Disease Professionals in Tarzana

1.
Aric Gregson MD

18321 Clark St
Tarzana, CA

2.
Allen Ameri

18321 Clark St
Tarzana, CA

Providers in Comprehensive Infectious Disease Consultants A Medical Corporation

1.Emily Alexiadis

18370 Burbank Blvd
Tarzana Ca 91356-2843
Comprehensive Infectious Disease Consultants A Medical Corporation
Nurse Practitioner

2.Aaron Shelub

18370 Burbank Blvd
Tarzana Ca 91356-2843
Comprehensive Infectious Disease Consultants A Medical Corporation
Infectious Disease

View all 2 members of Comprehensive Infectious Disease Consultants A Medical Corporation medical group